ExpreS2ion Biotechnologies successfully launches its IPO at First North Stockholm

Copenhagen, August 8, 2016ExpreS2ion Biotech Holding AB approved for listing on Nasdaq Stockholm First North. This entry was posted on July 27, 2016ExpreS2ion Biotech Holding AB (“ExpreS2ion “) announces that the Company has met the requirements for listing on Nasdaq Stockholm First North and today, July 27, it has received the stock exhange’s formal approval. The first…